Qube Research & Technologies Ltd - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$3,971,901
+66.2%
155,456
+86.6%
0.01%
+11.1%
Q2 2023$2,389,417
+1092.5%
83,313
+605.2%
0.01%
+800.0%
Q4 2022$200,365
-49.0%
11,814
+1.7%
0.00%
-75.0%
Q2 2021$393,000
-21.4%
11,620
-4.0%
0.00%
-50.0%
Q1 2021$500,000
+31.2%
12,106
-56.9%
0.01%
-50.0%
Q1 2020$381,000
-48.2%
28,057
-58.6%
0.02%
-30.4%
Q4 2019$736,00067,7020.02%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,400$1,784,0002.46%
Integral Health Asset Management, LLC 130,000$1,927,0000.37%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 20,916$310,0000.34%
Green Alpha Advisors, LLC 23,362$346,0000.29%
Nikko Asset Management Americas, Inc. 1,459,415$21,162,0000.27%
ARK Investment Management 2,181,703$32,333,0000.22%
Woodline Partners LP 877,524$13,005,0000.18%
FEDERATED HERMES, INC. 3,567,497$52,870,0000.16%
NinePointTwo Capital LLC 12,417$184,0000.07%
Formidable Asset Management, LLC 15,650$261,0000.06%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders